Keytru­da's cer­vi­cal can­cer da­ta; Ar­cutis’ of­fer­ing; Alaya.bio an­nounces a CAR-T deal

Keytru­da’s pos­i­tive cer­vi­cal can­cer da­ta: Mer­ck said Fri­day that its pow­er­house can­cer drug re­duced the risk of dis­ease pro­gres­sion or death in ad­vanced cer­vi­cal can­cer …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER